Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-15 5:29 pm Purchase | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | Allostery Investments LP | 1,065,016 7.3% | 1,065,016 (New Position) | View |
| 2024-04-11 09:51 am Purchase | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | JANUS HENDERSON GROUP PLC JHG | 1,080,107 7.4% | 1,080,107 (New Position) | View |
| 2024-04-09 8:57 pm Purchase | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | Avidity Partners Management LP | 1,000,000 6.9% | 1,000,000 (New Position) | View |
| 2024-04-05 7:38 pm Purchase | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | Western Standard LLC | 1,410,143 9.8% | 465,909 (+49.34%) | View |
| 2024-04-05 4:05 pm Purchase | 13D | ARCA BIOPHARMA INC PAR $.0 ABIO | Adage Capital Management L.P. | 1,200,000 8.28% | 1,200,000 (New Position) | View |
| 2024-02-07 1:08 pm Sale | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | BML Investment Partners L.P. | 706,930 4.9% | -151,326 (-17.63%) | View |
| 2023-09-11 4:01 pm Purchase | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | Western Standard LLC | 944,234 6.6% | 944,234 (New Position) | View |
| 2023-02-08 2:48 pm Purchase | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | BML Investment Partners L.P. | 858,256 5.95% | 96,401 (+12.65%) | View |
| 2022-07-08 4:30 pm Purchase | 13D | ARCA BIOPHARMA INC PAR $.0 ABIO | Funicular Funds LP | 2,581,119 17.91% | 2,581,119 (New Position) | View |
| 2022-06-21 4:30 pm Purchase | 13D | ARCA BIOPHARMA INC PAR $.0 ABIO | Funicular Fund LP | 2,581,119 17.91% | 183,838 (+7.67%) | View |
| 2022-05-27 4:40 pm Purchase | 13D | ARCA BIOPHARMA INC PAR $.0 ABIO | Ma-Weaver Jacob | 2,580,452 17.91% | 2,580,452 (New Position) | View |
| 2022-05-11 4:56 pm Purchase | 13D | ARCA BIOPHARMA INC PAR $.0 ABIO | Funicular Fund LP | 2,397,281 16.64% | 226,181 (+10.42%) | View |
| 2022-04-14 4:38 pm Purchase | 13D | ARCA BIOPHARMA INC PAR $.0 ABIO | Funicular Fund LP | 2,171,100 15.06% | 226,107 (+11.63%) | View |
| 2022-04-04 5:10 pm Purchase | 13D | ARCA BIOPHARMA INC PAR $.0 ABIO | Funicular Fund LP | 1,944,993 13.5% | 1,009,958 (+108.01%) | View |
| 2022-03-28 4:20 pm Purchase | 13D | ARCA BIOPHARMA INC PAR $.0 ABIO | Funicular Fund LP | 935,035 6.49% | 935,035 (New Position) | View |
| 2022-01-27 3:53 pm Purchase | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | BML Investment Partners L.P. | 761,855 5.3% | 761,855 (New Position) | View |
| 2021-02-10 1:45 pm Purchase | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | RENAISSANCE TECHNOLOGIES LLC | 205,500 2.2% | 62,928 (+44.14%) | View |
| 2021-02-10 10:30 am Sale | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | Altium Capital Management LP | 0 0% | -174,000 (Position Closed) | View |
| 2021-01-06 12:31 pm Sale | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | SABBY MANAGEMENT LLC | 0 0% | -194,013 (Position Closed) | View |
| 2020-06-10 3:06 pm Purchase | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | Altium Capital Management LP | 174,000 9.99% | 174,000 (New Position) | View |